On the occasion of the European Respiratory Society’s (ERS) Annual Congress in Amsterdam, ECDC and ERS today introduce a draft of the EU Standards for Tuberculosis Care (ESTC).
The ERS Annual Congress brings together the world's respiratory experts and professionals to meet, exchange views and share knowledge covering all aspects of respiratory medicine, novelties and most recent data presentations.
The Shiga toxin-producing E. coli outbreak in Germany during 2011 showed the value of a solid microbiology network and the need to increase the speed of notification of cases of infectious diseases in Europe.
The WHO Regional Committee for Europe approved a new action plan to tackle multi-drug resistant and extensively drug resistant tuberculosis (M/XDR-TB) today. This is another milestone in the European efforts to secure strong tuberculosis prevention and control across the region.
The second ECDC advisory group meeting will discuss progress and future challenges in reporting and monitoring following the commitment outlined in the Dublin Declaration.
Patient transfer between hospitals and in particular between countries, is a risk factor for the spread of bacteria that are resistant to last-line antibiotics. More specifically, for highly resistant bacteria, like carbapenamase-producing Enterobacteriaceae (CPE), the risk is heightened when patients are transferred from, or have received previous medical care in areas with high rates of bacterial resistance. These are conclusions from a risk assessment produced by ECDC that evaluated the risk to the citizens of Europe, of the spread of CPE through patient transfer between healthcare facilities, with special emphasis on cross-border transfer.